PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Rendo, V.* ; Schubert, M. ; Khuu, N.* ; Suarez Peredo Rodriguez, M.F.* ; Whyte, D.* ; Ling, X.* ; van den Brink, A.* ; Huang, K.* ; Swift, M.* ; He, Y.* ; Zerbib, J.* ; Smith, R.* ; Raaijmakers, J.* ; Bandopadhayay, P.* ; Guenther, L.M.* ; Hwang, J.H.* ; Iniguez, A.* ; Moody, S.* ; Seo, J.H.* ; Stover, E.H.* ; Garraway, L.* ; Hahn, W.C.* ; Stegmaier, K.* ; Medema, R.H.* ; Chowdhury, D.* ; Colomé-Tatché, M. ; Ben-David, U.* ; Beroukhim, R.* ; Foijer, F.*

A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer.

Nat. Commun. 16:1077 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
While the effect of amplification-induced oncogene expression in cancer is known, the impact of copy-number gains on "bystander" genes is less understood. We create a comprehensive map of dosage compensation in cancer by integrating expression and copy number profiles from over 8000 tumors in The Cancer Genome Atlas and cell lines from the Cancer Cell Line Encyclopedia. Additionally, we analyze 17 cancer open reading frame screens to identify genes toxic to cancer cells when overexpressed. Combining these approaches, we propose a class of 'Amplification-Related Gain Of Sensitivity' (ARGOS) genes located in commonly amplified regions, yet expressed at lower levels than expected by their copy number, and toxic when overexpressed. We validate RBM14 as an ARGOS gene in lung and breast cancer cells, and suggest a toxicity mechanism involving altered DNA damage response and STING signaling. We additionally observe increased patient survival in a radiation-treated cancer cohort with RBM14 amplification.
Impact Factor
Scopus SNIP
Altmetric
15.700
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Therapeutic Vulnerabilities; Dosage Sensitivity; Protein; Resistance; Dependency; Generation; Senescence; Deletion; Kinase; Enzyme
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 16, Heft: 1, Seiten: , Artikelnummer: 1077 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Computational Biology (ICB)
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-554200-001
Förderungen Marie Sklstrok
Break Through Cancer
Gray Matters Brain Cancer Foundation
NIH
ERC Starting Grant
Swedish Research Council
Brain Tumor Charity
Dutch Cancer Society
odowska-Curie postdoctoral fellowship
odowska-Curie postdoctoral fellowship (101068734)
Brown Fund for Innovative Cancer Informatics
DOI 10.1038/s41467-025-56301-2
WOS ID 001408553700011
PubMed ID 39870664
Erfassungsdatum 2025-03-26
[➜Korrektur melden]